Cogent Biosciences is preparing parallel FDA submissions for bezuclastinib across three indications following positive pivotal trial results, with potential launches beginning in late 2026 and full commercialization expected by early 2027.
A major meta-analysis of 19 randomized trials involving 123,940 participants found that only six side effects are actually caused by statins, challenging long-standing concerns about the drugs' safety profile.
The FDA approved Tecvayli plus Darzalex Faspro for relapsed/refractory multiple myeloma in March 2026, and Darzalex Faspro-based quadruplet D-VRd for newly diagnosed transplant-ineligible patients in January 2026.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07522918 |
Single-Session Extraoral PBM After Third Molar Extraction |
COMPLETED | NA |
| NCT07442344 |
Care Bundle for Prevention of Skin Complications and Edema in Restrained Patients |
NOT_YET_RECRUITING | NA |
| NCT07418814 |
Infant Massage for Lymphedema and Comfort in Preterm Newborns |
NOT_YET_RECRUITING | NA |
| NCT07062757 |
Lymphatic Drainage Massage and Melatonin in Post-Orthognathic Surgery Pain and Edema |
ENROLLING_BY_INVITATION | NA |
| NCT07033039 |
Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre |
RECRUITING | NA |
| NCT06995144 |
Comparing Natriuretic Effects of ER Torsemide to IR Torsemide in Patients With Heart Failure |
COMPLETED | PHASE4 |
| NCT06938048 |
COMPARISON OF BANDAGE IN HAND EDEMA |
ENROLLING_BY_INVITATION | NA |
| NCT06758258 |
Negative Pressure Wound Therapy in Oral Surgery |
COMPLETED | NA |
| NCT06697470 |
Muscle and Subcutaneous Tissue Variation by Ultrasound and Impedance Linked to Fluid Balance in ICU Patients |
RECRUITING | |
| NCT06484608 |
Comparison of Isotonic Versus Hypotonic Fluids in Neonates for Maintenance Fluid Therapy After Surgery |
COMPLETED | NA |
